IPO Issue Details
Issue Price / Price Band₹65 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size2,000 Shares per Lot
Total Issue Size62,16,000 shares (aggregating up to ₹37.92 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenThu, 02 May 2019
Subscription CloseWed, 15 May 2019
Anchor AllotmentWed, 01 May 2019
Basis of AllotmentMon, 20 May 2019
Initiation of RefundsTue, 21 May 2019
Credit of Shares to DematWed, 22 May 2019
Listing DateThu, 23 May 2019
UPI Mandate Deadline2019-05-15
Application & Investment Details
Retail — Min (1 Lots)₹1,22,000 — 2,000 shares
Retail — Max (13 Lots)₹1,690,000 (13 Lots)
HNI — Min (2 Lots)₹2,44,000 — 4,000 shares
Net Offer to Public59,00,000 shares (aggregating up to ₹35.99 Cr)
Reserved for Market Maker3,16,000 shares (aggregating up to ₹2.05 Cr)
Pre-IPO Promoter Holding1,71,44,764 shares
Post-IPO Promoter Holding2,33,60,764 shares
About Cian Healthcare Ltd.
Incorporated in 2003, Cian Healthcare Limited is a multinational manufacturing company certified by WHO-GMP & ISO -9001:2015 and Food and Drug Control Administration to work in the area of Food supplement, Sexual Wellness, Cosmeceuticals, Nutraceutical, Ayurvedic, and Pharmaceutical products. The manufacturing process of the company complies with the prescribed rules and regulations of the World Health Organization.The company is engaged in developing, manufacturing and commercialising the pharmaceutical products under 12 therapeutic divisions and 10 sales division. The company operates the business under the brand and is also involved in government supplies, export and third-party manufacturing activities.Products:The product list of the company includes Sachet, Gels, Lotions, Creams, Ointments, Liquid Orals, Capsules, and Tablets. Apart from this, the company also owns a special licence to manufacture veterinary products such as Venky's and SAVAvet. The company manufactures pharmaceutical products for both the foreign and domestic markets.Category wise sales:As on 31st March 2018, the total company sale was comprising 37% from contract manufacturing, 24% from government supplies, 23% from franchise business, and 16% from export sales.The competitive strengths of the company are:1. PAN India presence2. Promoters' 15 years of experience in the field3. Good purchasing power4. Strong distribution network5. Low-cost operations
Objects of the Issue
Cian Healthcare Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Upgradation of existing plant i.e. Unit 1 situated at Roorkee, Uttarakhand India
3.50
2
2 Margin money for Setting up of manufacturing facility i.e. Unit 2 situated at Roorkee, Uttarakhand, India
7.28
3
3 Enhancement of our Company’s brand through advertising and other brand-building activities
1.50
4
4 Long term working capital requirements
10.00
5
5 Acquisitions and other strategic initiatives
7.09
6
6 General corporate purposes
4.74
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,71,44,764 shares
Post-IPO Promoter Holding
2,33,60,764 shares